AdipoRon prevents myostatin‐induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line
Abstract Liver diseases such as non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) are characterized by excess hepatic accumulation of lipid droplets and triglycerides which are associated with defective insulin action. Myostatin (Mstn) and adiponectin, secreted by mu...
Main Authors: | Xin‐Hua Liu, Jiang Ping Pan, William A. Bauman, Christopher P. Cardozo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-07-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.14152 |
Similar Items
-
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
by: Ersilia Nigro, et al.
Published: (2021-05-01) -
AdipoRon may be benefit for atherosclerosis prevention
by: Maryam Esfahani, et al.
Published: (2017-02-01) -
AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation
by: Zhang YZ, et al.
Published: (2019-10-01) -
Distribution of Adiponectin Receptors in the Brain of Adult Mouse: Effect of a Single Dose of the Adiponectin Receptor Agonist, AdipoRON, on Ischemic Stroke
by: Julien Clain, et al.
Published: (2022-05-01) -
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice
by: Hubert Zatorski, et al.
Published: (2021-05-01)